Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

Ryerson University

$25,000.00

Optimization of a three-stage compounding process for the production of the nasal spray in Apotex through the rheological characterization of the bulk suspension

FY 2016-17

Summary
The bulk suspension nasal spray liquid obtained throughout the three-stages compounding process is anon-Newtonian fluid exhibiting a complex rheology. Earlier studies have demonstrated a significantrelationship between the rheological properties of a formulation and the way in which atomization occursduring actuation of a nasal pump spray. Also, rheological changes have impact on the duration of the stablephase, and affect the sensitivity of the stable phase particle size to changes in the actuation velocity. Currently,the rheology of the compound at three-stages of cellulose particle suspension, preservative phase and activephase has not been fully characterized as a function of the operating conditions and the rate/order of materialaddition. Apotex a leading medicinal nasal spray manufacturer is interested in characterizing the rheologicalbehavior of this complex mixture in order to enhance the quality of the nasal spray drugs.The existing compounding system has not been properly designed therefore; uniform bulk dispersion cannot beachieved efficiently in utilizing three-stage compounding process. The rheological behaviour of the bulksuspension used for production of spray drugs is a function of several process variables i.e., agitation rate,mixing time, temperature, order/rate of material addition. In fact, rheology of the bulk suspension changeswhen each of the nine active and excipient materials are added throughout a three-stage compounding process.The main objective of the proposed research is to investigate the rheology of this compound as a function ofthe operating conditions for all three stages of compounding.This research work is essential not only to the Apotex but also to the Canadian pharmaceutical industry. Theglobal inhalation/nasal spray drugs market was valued at US$21.8 bn in 2014 and is estimated to reachUS$35.5 bn by 2023. The proposed research will contribute to the compatibility of the Canadianpharmaceutical industry in the global market. Finally, increasing advancements related to inhalation and nasalspray medication formulation would propel health, wellness and quality of life of Canadians.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
505472-2016
Name nom
Lohi, Ali
Department département
Chemical Engineering
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
1
Nb partie
1
Application title
Optimization of a three-stage compounding process for the production of the nasal spray in Apotex through the rheological characterization of the bulk suspension
Keyword
NSERC
Application summary
The bulk suspension nasal spray liquid obtained throughout the three-stages compounding process is anon-Newtonian fluid exhibiting a complex rheology. Earlier studies have demonstrated a significantrelationship between the rheological properties of a formulation and the way in which atomization occursduring actuation of a nasal pump spray. Also, rheological changes have impact on the duration of the stablephase, and affect the sensitivity of the stable phase particle size to changes in the actuation velocity. Currently,the rheology of the compound at three-stages of cellulose particle suspension, preservative phase and activephase has not been fully characterized as a function of the operating conditions and the rate/order of materialaddition. Apotex a leading medicinal nasal spray manufacturer is interested in characterizing the rheologicalbehavior of this complex mixture in order to enhance the quality of the nasal spray drugs.The existing compounding system has not been properly designed therefore; uniform bulk dispersion cannot beachieved efficiently in utilizing three-stage compounding process. The rheological behaviour of the bulksuspension used for production of spray drugs is a function of several process variables i.e., agitation rate,mixing time, temperature, order/rate of material addition. In fact, rheology of the bulk suspension changeswhen each of the nine active and excipient materials are added throughout a three-stage compounding process.The main objective of the proposed research is to investigate the rheology of this compound as a function ofthe operating conditions for all three stages of compounding.This research work is essential not only to the Apotex but also to the Canadian pharmaceutical industry. Theglobal inhalation/nasal spray drugs market was valued at US$21.8 bn in 2014 and is estimated to reachUS$35.5 bn by 2023. The proposed research will contribute to the compatibility of the Canadianpharmaceutical industry in the global market. Finally, increasing advancements related to inhalation and nasalspray medication formulation would propel health, wellness and quality of life of Canadians.
Ryerson University - $25,000 Grant (2016-17) | Canada Spends